MAP2K7 and melanoma: In melanomas, EXT1 loss may promote metastatic spread through heparan sulfate deficiency10 and induce resistance to DNA‐damaging agents through intracellular signaling activation (e.g., EGFR/JNK/MEK/ERK signaling).45